Market Overview

DuPont's Industrial Biosciences Unit to Buy Verdezyen's Xylose Isomerase Technology

Related DD
Top 4 Large-Cap Stocks In The Agricultural Chemicals Industry With The Highest ROE
Materials Sector Leading the Pack in Q3 Earnings Season: 3 ETFs in Focus - ETF News And Commentary
Making Money With Charles Payne: 10/29/14 (Fox Business)

Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, announced the sale of its proprietary xylose isomerase technology, enabling the metabolism of 5-carbon sugars, to DuPont Industrial Biosciences, a world leader in science and innovation.

Under the terms of the sale, DuPont has purchased rights to Verdezyne's patented xylose isomerase technology, covered by U.S. Patent Nos. 8,114,974 and 8,093,037, for use in the rapidly-commercializing biofuels and biochemical fields. This technology allows the fast and complete utilization of biomass-sourced C5 sugars in production of various products of choice. This technological breakthrough was highlighted in a recent Journal of Industrial Microbiology & Biotechnology article published August 2012.

Posted-In: News M&A

 

Related Articles (DD)

Around the Web, We're Loving...

Get Benzinga's Newsletters